Arabic Arabic English English French French German German
dark

NCCN Announces Selected Projects to Study Neratinib in Collaboration with Puma Biotechnology, Inc.

The National Comprehensive Cancer Network ® ( NCCN ® ) Oncology Research Program ( ORP ) today announced three research projects that have been selected for funding to evaluate neratinib in various tumor types. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of Directors

Next Post

Saama Announces Support for AWS Health Initiative

Related Posts
Total
0
Share